Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Integr Biol (Camb) ; 3(4): 255-66, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21437329

ABSTRACT

Gap junctions (GJ) can no longer be thought of as simple channel forming structures that mediate intercellular communication. Hemi-channel and channel-independent functions of connexins (Cxs) have been described and numerous Cx interacting partners have been uncovered ranging from enzymes to structural and scaffolding molecules to transcription factors. With the growing number of Cx partners and functions, including well-documented roles for Cxs as conditional tumor suppressors, it has become essential to understand how Cxs are regulated in a context-dependent manner to mediate distinct functions. In this review we will shed light on the tissue and context-dependent regulation and function of Cxs and on the importance of Cx-interactions in modulating tissue-specific function. We will emphasize how the context-dependent functions of Cxs can help in understanding the impact of Cx mis-expression on cancer development and, ultimately, explore whether Cxs can be used as potential therapeutic targets in cancer treatment. In the end, we will address the need for developing relevant assays for studying Cx and GJ functions and will highlight how advances in bioengineering tools and the design of 3D biological platforms can help studying gap junction function in real time in a non-intrusive manner.


Subject(s)
Connexins/physiology , Gap Junctions/physiology , Animals , Humans , Neoplasms/metabolism
2.
Leukemia ; 21(8): 1792-801, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17568816

ABSTRACT

Kaposi's sarcoma (KS)-associated herpes virus (KSHV) is the causative agent of primary effusion lymphoma and of KS. Primary effusion lymphoma (PEL) is an aggressive proliferation of B cells. Conventional chemotherapy has limited benefits in PEL patients, and the prognosis is very poor. We previously reported that treatment of human T-cell leukemia virus type 1 (HTLV-1)-associated adult T-cell leukemia/lymphoma cells either with arsenic trioxide (As) combined to interferon-alpha (IFN-alpha) or with the bortezomib (PS-341) proteasome inhibitor induces cell cycle arrest and apoptosis, partly due to the reversal of the constitutive nuclear factor-kappaB (NF-kappaB) activation. PEL cells also display an activated NF-kappaB pathway that is necessary for their survival. This prompted us to investigate the effects of PS-341, or of the As/IFN-alpha combination on PEL cells. A dramatic inhibition of cell proliferation and induction of apoptosis was observed in PS-341 and in As/IFN-alpha treated cells. This was associated with the dissipation of the mitochondrial membrane potential, cytosolic release of cytochrome c, caspase activation and was reversed by the z-VAD caspase inhibitor. PS-341 and As/IFN-alpha treatment abrogated NF-kappaB translocation to the nucleus and decreased the levels of the anti-apoptotic protein Bcl-X(L). Altogether, these results provide a rational basis for a future therapeutic use of PS-341 or combined As and IFN-alpha in PEL patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Apoptosis/drug effects , Boronic Acids/pharmacology , Caspases/metabolism , Herpesvirus 8, Human/physiology , Lymphoma/pathology , Lymphoma/virology , Pyrazines/pharmacology , Arsenic Trioxide , Arsenicals/administration & dosage , Bortezomib , Cell Proliferation/drug effects , Humans , Interferon-alpha/administration & dosage , Lymphoma/enzymology , Membrane Potential, Mitochondrial/drug effects , NF-kappa B/metabolism , Oxides/administration & dosage , Protease Inhibitors/pharmacology , bcl-X Protein/metabolism
3.
Cytokine ; 36(1-2): 1-8, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17161612

ABSTRACT

In inflammatory bowel disease, cells that infiltrate the mucosa regulate intestinal epithelial cell function partly through release of pro- and anti-inflammatory cytokines. The aim of this study is to evaluate the role of the anti-inflammatory cytokine, IL-10, on normal mouse intestinal epithelial cells (Mode-K) in the absence or presence of IL-1. Western blotting assays and immunocytochemistry were used to identify the presence of IL-1 and IL-10 receptors on Mode-K cells; and electrophoretic mobility shift assays were used to study the activation of NF-kappaB transcription factor. Stimulation of Mode-K cells with IL-1 or IL-10 did not modify IL-1 and IL-10 receptor expression levels. IL-1 induced the synthesis of the enzyme cyclooxygenase-2 (COX-2) through the activation and translocation of p65 subunit of NF-kappaB. Inhibition of translocated p65 binding to DNA, inhibited COX-2 production and induced apoptosis. IL-10 inhibited IL-1-induced effects on IKB-alpha and IKB-beta proteins through stabilizing these proteins; subsequently causing inhibition of NF-kappaB translocation to the nucleus and any subsequent induction of COX-2. These data support a role for IL-10 in the regulation of IEC function under inflammatory conditions and the involvement of COX-2 in inhibiting apoptosis in mouse intestinal epithelial cells.


Subject(s)
Epithelial Cells/drug effects , Epithelial Cells/metabolism , Interleukin-10/pharmacology , Intestinal Mucosa/metabolism , Intestines/drug effects , NF-kappa B/metabolism , Animals , Cells, Cultured , Cyclooxygenase 2/metabolism , Dinoprostone/metabolism , I-kappa B Kinase/metabolism , Inflammation/metabolism , Interleukin-1/pharmacology , Mice , NF-kappa B/antagonists & inhibitors , Receptors, Interleukin-1/metabolism , Receptors, Interleukin-10/metabolism
4.
Carcinogenesis ; 22(12): 1955-63, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11751425

ABSTRACT

Retinoids are essential for normal epidermal differentiation and are used for the prevention and treatment of numerous skin disorders and cancers in humans. In previous studies, we have shown that retinoic acid receptors (RARs) -alpha and -gamma are down-regulated during skin tumor progression. The transduction of v-ras(Ha) into primary mouse keratinocytes is sufficient to reduce both RARalpha and RARgamma protein levels as well as inhibit their transactivation functions. Our primary objective is to investigate the roles that RARalpha and RARgamma play in keratinocyte tumor cell proliferation. Through retroviral gene transduction, we overexpressed RARalpha or RARgamma into neoplastic mouse epidermal cells with down-regulated endogenous RAR proteins. Following all-trans retinoic acid (RA) treatment, RARalpha- and RARgamma-transduced cell lines exhibit a progressive, dose-dependent growth inhibition relative to the control LXSN cell lines. Further characterization of RAR-transduced cells following RA treatment reveals that both RARalpha and RARgamma cause a decrease in S-phase population, while only RARalpha causes a simultaneous G(0)/G(1) block as evidenced by reduced [(3)H]-thymidine incorporation and flow cytometric analysis of DNA content. Following RA treatment, both receptors cause an early, transient increase in the cyclin-dependent kinase inhibitor (CDKI) p21 proteins, while only RARalpha causes a simultaneous sharp, brief increase in the CDKI p16 protein. A later decrease in cyclin D(1) protein is also evident in RARalpha- and RARgamma-transduced cells. Chromatin condensation and PARP cleavage are observed in both RARalpha- and RARgamma-transduced cells indicating an RA-induced apoptosis that may be caspase dependent. Furthermore, both receptors cause a late upregulation and apparent cleavage of the squamous differentiation marker protein kinase C (PKC)-eta. These results suggest that RARalpha and RARgamma enhance growth suppression and apoptosis of neoplastic epidermal keratinocytes. This growth inhibitory effect of both retinoid receptors in neoplastic keratinocytes may be achieved through distinct as well as overlapping mechanisms of cell cycle control.


Subject(s)
Apoptosis/drug effects , Receptors, Retinoic Acid/metabolism , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Tretinoin/pharmacology , Animals , Cell Differentiation/drug effects , Cell Division/drug effects , Cell Line, Transformed , Cell Size/drug effects , Electrophoretic Mobility Shift Assay , Epidermal Cells , Epidermis/drug effects , Epidermis/metabolism , Keratinocytes/cytology , Keratinocytes/drug effects , Keratinocytes/metabolism , Mice , Receptors, Retinoic Acid/genetics , Retinoic Acid Receptor alpha , Skin Neoplasms/genetics , Transduction, Genetic , Tumor Cells, Cultured , Retinoic Acid Receptor gamma
5.
Domest Anim Endocrinol ; 21(3): 143-59, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11707361

ABSTRACT

Developmental regulation of growth promoting activities in mammary secretions of pregnant Awassi ewes was defined, and growth factors contained in these secretions were partially purified and characterised. Mammary secretions from pregnant ewes enhanced fibroblast cell (AKR-2B) and mammary cell (CID-9 cell strain) proliferation to levels comparable to that induced by 10% Foetal calf serum. Major milk proteins in mammary secretions collected from pregnant ewes one month prior to lambing up to one week after lambing, were resolved by SDS-PAGE, while gelatinases were resolved by zymography. Gelatinase activity was noted prior to P134 and decreased thereafter to reach a minimum during lactation. This decrease was concomitant with the onset of casein production. It is during this critical developmental period that highest growth promoting activity in mammary secretions was detected. Secretions with highest growth promoting activity were fractionated by ion exchange and gel filtration chromatography. Two heat-resistant, trypsin/chymotrypsin sensitive, growth-promoting activities were characterised. The first, designated ovine mammary derived growth factor-1 (oMDGF-1), had around a 30 kDa molecular weight and eluted at 0.65 M NaCl gradient on cation ion exchange chromatography. The second, oMDGF-2, eluted under gel filtration conditions at a molecular weight of 50 kDa and 150 kDa. oMDGF-1 induced changes in Connexin 43, but not in beta-casein mRNA expression by CID-9 mammary cells. In conclusion, growth factor activities in ewe mammary secretions peak during gestation at a period that overlaps maximal gelatinase expression and precedes milk protein synthesis. The factors modulate mammary cell function and may play a role in mammary gland development.


Subject(s)
Growth Substances/isolation & purification , Mammary Glands, Animal/metabolism , Milk Proteins/isolation & purification , Sheep/physiology , Animals , Blotting, Northern , Caseins/biosynthesis , Caseins/isolation & purification , Caseins/metabolism , Cell Division , Cells, Cultured , Chromatography, Agarose , Chromatography, Ion Exchange , Connexin 43/biosynthesis , Connexin 43/isolation & purification , Connexin 43/metabolism , Electrophoresis, Polyacrylamide Gel , Female , Gelatinases/biosynthesis , Gelatinases/metabolism , Gene Expression Regulation, Developmental/physiology , Growth Substances/biosynthesis , Growth Substances/physiology , Lactation , Mammary Glands, Animal/growth & development , Mice , Milk Proteins/biosynthesis , Pregnancy , RNA/isolation & purification , RNA/metabolism
6.
Nutr Cancer ; 39(1): 108-16, 2001.
Article in English | MEDLINE | ID: mdl-11588891

ABSTRACT

We have shown that naturally occurring tannins possess antitumor promotion activity in mouse skin. In the present investigation, we studied the ability of a hydrolyzable tannin, gallotannin (GT), and a condensed tannin extracted from red alder (RA) bark to inhibit 1,2-dimethylhydrazine (DMH)-induced colonic aberrant crypt foci (ACF) and tumors in Balb/c mice. In addition, we determined the ability of GT to inhibit the proliferation and to induce apoptosis in a human colon cancer cell line (T-84). Mice were given tannins by intraperitoneal injections, by gavage, or in drinking water before treatment with DMH for 24 weeks. Alternatively, mice were given tannins by intraperitoneal injection or gavage for only 2 weeks before DMH administration, then tannin administration was discontinued and mice were treated with DMH for 24 weeks. The multiplicity, size, and distribution of ACF and tumors were significantly inhibited by GT and RA in the above treatment regimens. The most effective treatments included GT by gavage, RA bark extract by intraperitoneal injection, and either tannin dissolved in drinking water. Extent of inhibition of ACF and tumors was gender independent. In cell culture experiments, GT treatment for three days inhibited the growth of T-84 cells, with a concentration resulting in half-maximal inhibition estimated to be 20 micrograms/ml. The treatment was not cytotoxic to cells at 1-40 micrograms/ml. Interestingly, at 10 micrograms/ml, GT induced apoptosis in T-84 cells as determined by the Hoechst DNA staining technique. Collectively, these findings support a potential role for tannins as chemopreventive agents against colon cancer.


Subject(s)
Colonic Neoplasms/prevention & control , Precancerous Conditions/prevention & control , Tannins/therapeutic use , 1,2-Dimethylhydrazine/toxicity , Animals , Apoptosis/drug effects , Carcinogens/toxicity , Colon/drug effects , Colon/pathology , Colonic Neoplasms/chemically induced , Colonic Neoplasms/drug therapy , Drug Administration Routes , Female , Male , Mice , Mice, Inbred BALB C , Phytotherapy , Precancerous Conditions/chemically induced , Precancerous Conditions/drug therapy , Tannins/administration & dosage , Tannins/pharmacology , Tumor Cells, Cultured
7.
Inflamm Res ; 50(7): 375-81, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11506393

ABSTRACT

OBJECTIVE AND DESIGN: the aim of the study was to decipher the molecular signals involved in IL-I's action on intestinal epithelial cells (IEC). MATERIALS AND METHODS: Mode-K cells, used as a model of IEC, were treated with IL-I, and PLA2 activity and PGE2, ceramide, and cyclooxygenase-2 (COX-2) levels were measured using enzyme-immuno-assay kit, EIA, thin-layer chromatography and western blotting assays respectively. RESULTS: IL-I caused a concentration- and time-dependent increase in PLA2 activity (3-fold increase), in ceramide levels (peak increase = 10.5 +/- 0.9 pmol/nmol phosphate), and in COX-2 and PGE2 levels. PGE2 increase was biphasic with an early peak at 10 min (around 5 ng/mg protein) due to increased PLA2 activity. The later peak (13.1 +/- 1.9 ng/mg protein) at 4 h was due to COX-2 induction. CONCLUSION: In conclusion, these findings demonstrate that IL-I regulates IEC function through two pathways, the PLA2 and the sphingomyelin pathways, both of which are capable of modulating the inflammatory process.


Subject(s)
Epithelial Cells/drug effects , Interleukin-1/pharmacology , Phospholipids/physiology , Signal Transduction/drug effects , Blotting, Northern , Blotting, Western , Cells, Cultured , Ceramides/metabolism , Cyclooxygenase 1 , Cyclooxygenase 2 , Dinoprostone/metabolism , Electrophoresis, Polyacrylamide Gel , Humans , Intestines/cytology , Intestines/drug effects , Isoenzymes/biosynthesis , Membrane Proteins , Phospholipases A/metabolism , Phospholipases A2 , Prostaglandin-Endoperoxide Synthases/biosynthesis , Proteins/chemistry , Proteins/isolation & purification , Recombinant Proteins/pharmacology , Sphingomyelins/metabolism
8.
Blood ; 96(8): 2849-55, 2000 Oct 15.
Article in English | MEDLINE | ID: mdl-11023521

ABSTRACT

Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature activated T cells resistant to conventional chemotherapy. The viral transactivator protein Tax plays a critical role in HTLV-I-induced transformation and apoptosis resistance by inducing I kappa B-alpha degradation, resulting in the activation of the NF-kappa Bpathway. In these HTLV-I-transformed cells, arsenic trioxide (As) and interferon (IFN)-alpha synergize to induce cell cycle arrest and apoptosis. We demonstrate that cell death induction is only partly dependent upon caspase activation and is not associated with modulation of bcl-2, bax, or p53 expression. However, combined As and IFN induce the degradation of Tax, associated with an up-regulation of I kappa B-alpha resulting in a sharp decrease in RelA DNA binding nuclear factor (NF)-kappa B complexes because of the cytoplasmic retention of RelA. Taken the role of Tax in HTLV-I-induced transformation, its down-regulation probably accounts for cell death induction through inactivation of the NF-kappa B pathway. Such specific targeting of the viral oncoprotein by As-IFN treatment, reminiscent of As targeting of promyelocytic leukemia/retinoic acid receptor-alpha in acute promyelocytic leukemia, provides strong rational for combined As-IFN therapy in ATL patients. (Blood. 2000;96:2849-2855)


Subject(s)
Apoptosis/drug effects , Arsenicals/pharmacology , Cell Transformation, Viral/drug effects , Gene Expression Regulation, Leukemic/drug effects , Gene Expression Regulation, Viral/drug effects , Gene Products, tax/physiology , Human T-lymphotropic virus 1/physiology , I-kappa B Proteins , Interferon-alpha/pharmacology , Leukemia-Lymphoma, Adult T-Cell/genetics , NF-kappa B/metabolism , Neoplasm Proteins/physiology , Oxides/pharmacology , Transcriptional Activation/drug effects , Arsenic Trioxide , Caspases/physiology , Cell Cycle/drug effects , Cell Line, Transformed , DNA/metabolism , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Drug Synergism , Enzyme Activation , Humans , Leukemia-Lymphoma, Adult T-Cell/pathology , Ligases/metabolism , Macromolecular Substances , NF-KappaB Inhibitor alpha , T-Lymphocytes/metabolism , T-Lymphocytes/virology , Tumor Cells, Cultured
9.
Leukemia ; 14(4): 716-21, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10764160

ABSTRACT

The combination of the anti-viral agents, zidovudine (AZT) and interferon-alpha (IFN), is a potent treatment of HTLV-I-associated adult T cell leukemia/lymphoma (ATL). In this study we investigate the possible mechanism of action of this combination by examining several cellular parameters including cell proliferation, cell cycle distribution and apoptosis. The ATL-derived T cell lines HuT-102 and MT-2 served as models. HTLV-I negative T cell lines (CEM and Jurkat) were used as controls. No significant modification of cell growth was observed except at suprapharmacological doses of AZT and IFN. Moreover, these effects were less pronounced in HTLV-I-infected cell lines compared to control cell lines. AZT and IFN treatment did not induce any significant modification of the expression of bcl-2 and p53. Interestingly no in vitro cytotoxic effect of AZT/IFN combination was observed on fresh leukemic cells derived from an acute ATL patient at diagnosis despite achievement of in vivo complete remission using the same therapy. These results suggest that the therapeutic effect of AZT and IFN is not through a direct cytotoxic effect of these drugs on the leukemic cells.


Subject(s)
Antimetabolites, Antineoplastic/pharmacology , Immunologic Factors/pharmacology , Interferon-alpha/pharmacology , Leukemia-Lymphoma, Adult T-Cell/drug therapy , Neoplastic Stem Cells/drug effects , T-Lymphocytes/drug effects , Zidovudine/pharmacology , Aged , Antimetabolites, Antineoplastic/therapeutic use , Apoptosis/drug effects , Biomarkers, Tumor/analysis , Cell Survival/drug effects , Combined Modality Therapy , DNA, Neoplasm/analysis , Drug Synergism , Female , Human T-lymphotropic virus 1/isolation & purification , Humans , Immunologic Factors/therapeutic use , Interferon-alpha/therapeutic use , Jurkat Cells/drug effects , Leukemia-Lymphoma, Adult T-Cell/pathology , Remission Induction , Tumor Cells, Cultured/drug effects , Zidovudine/therapeutic use
10.
J Renin Angiotensin Aldosterone Syst ; 1(4): 369-78, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11967826

ABSTRACT

Clinical evidence points to a role for angiotensin II (Ang II) in the post-infarction remodelling of cardiac hypertrophy. The present study was designed to investigate the remodelling process in an animal model of myocardial infarction (MI) using the following criteria: 1) histological studies to examine the re-vascularisation process and collagen deposition in different regions of the myocardium; 2) histological evidence to investigate the cell type distribution using cell-specific markers; 3) histological and Western blot analysis to localise Ang II receptor subtypes (AT(1)-receptor and AT(2)-receptor) and to study their regulation; 4) kinetics of the binding of Ang II to its receptors in a heart perfusion model; and 5) to assess the effect of the Ang II antagonist (losartan) on these parameters. MI was induced by ligation of the left anterior descending coronary artery of Sprague-Dawley rats. Four different animal groups were established: 1) sham-operated, non-treated; 2) sham-operated, treated with losartan; 3) myocardial infarct, non-treated; and 4) myocardial infarct, treated with losartan. In infarcted rat hearts, fibroblasts and collagen types I and III increased in the remnant viable region of the left ventricle compared with sham-operated rats. One month of losartan treatment in myocardial infarcted rats revealed insignificant changes in fibroblasts and collagen types I and III compared with sham controls. Also, myocardial infarction increased AT(1)-receptor protein levels compared with sham-operated controls, as judged by Western blotting. In losartan-treated myocardial infarct animals, no changes were detected at the level of AT(1)-receptor expression compared with non-treated myocardial infarct rats. Binding studies of Ang II on endothelial cell lining and directly on myocytes in sham-operated and infarcted perfused rat hearts revealed that, in myocardial infarcted-animals, Ang II binding affinity increased both in the endothelium and in myofibres. This may be considered a major putative effect of the peptide in potentiating the pharmacodynamics of hypertrophy. In losartan-treated myocardial infarcted-animals, a marked increase in the binding affinities of Ang II for the AT(2)-receptor subtype was observed. Hence, potential cardioprotective effects of the AT(1)-receptor antagonist are proposed.


Subject(s)
Angiotensin II/metabolism , Extracellular Matrix/physiology , Myocardial Infarction/metabolism , Animals , Biomarkers , Cardiomegaly/pathology , Cicatrix/pathology , Coronary Circulation/drug effects , Female , Kinetics , Myocardial Infarction/pathology , Myocardial Infarction/physiopathology , Myocardium/metabolism , Myocardium/pathology , Perfusion , Rats , Rats, Sprague-Dawley , Receptor, Angiotensin, Type 1 , Receptors, Angiotensin/metabolism , Time Factors , Tissue Distribution
11.
Am J Physiol ; 276(4): F521-7, 1999 04.
Article in English | MEDLINE | ID: mdl-10198410

ABSTRACT

We have previously demonstrated that a plasma natriuretic factor is present in Alzheimer's disease (AD), but not in multi-infarct dementia (MID) or normal controls (C). We postulated that the natriuretic factor might induce the increased cytosolic calcium reported in AD by inhibiting the sodium-calcium antiporter, thereby activating the apoptotic pathway. To test for a factor in AD plasma that induces apoptosis, we exposed nonconfluent cultured LLC-PK1 cells to plasma from AD, MID, and C for 2 h and performed a terminal transferase-dUTP-nick-end labeling (TUNEL) assay. The plasma from AD increased apoptosis nearly fourfold compared with MID and C. The effect was dose dependent and the peak effect was attained after a 2-h exposure. Additionally, apoptotic morphology was detected by electron microscopy, and internucleosomal DNA cleavage was found. We inhibited apoptosis by removing calcium from the medium, inhibiting protein synthesis with cycloheximide, alternately boiling or freezing and thawing the plasma, and digesting a partially purified fraction with trypsin. Heating AD plasma to 56 degrees C did not deactivate the apoptotic factor. These results demonstrate the presence of an apoptotic factor in the plasma of patients with AD.


Subject(s)
Alzheimer Disease/blood , Apoptosis/physiology , Animals , Blood Physiological Phenomena , DNA Fragmentation/physiology , Dementia, Multi-Infarct/blood , Humans , In Situ Nick-End Labeling , LLC-PK1 Cells/physiology , LLC-PK1 Cells/ultrastructure , Microscopy, Electron , Nucleosomes/metabolism , Reference Values , Swine
12.
Blood ; 93(1): 278-83, 1999 Jan 01.
Article in English | MEDLINE | ID: mdl-9864171

ABSTRACT

Human T-cell lymphotropic virus type I (HTLV-I) is the causative agent of adult T-cell leukemia/lymphoma (ATL). ATL is an aggressive proliferation of mature activated T cells associated with a poor prognosis. The combination of the antiviral agents, zidovudine (AZT) and interferon (IFN), is a potent treatment of ATL. Recently, arsenic trioxide (As) was shown to be an effective treatment of acute promyelocytic leukemia (APL). We have tested the effects of the combination of As and IFN on cell proliferation, cell cycle phases distribution, and apoptosis in ATL-derived or control T-cell lines. A high synergistic effect between IFN and As was observed in ATL-derived cell lines in comparison to the control cell lines, with a dramatic inhibition of cell proliferation, G1 arrest, and induction of apoptosis. Similar results were obtained with fresh leukemia cells derived from an ATL patient. Although the mechanisms involved are unclear, these results could provide a rational basis for combined As and IFN treatments in ATL.


Subject(s)
Apoptosis/drug effects , Arsenicals/pharmacology , Cell Cycle/drug effects , Cell Transformation, Viral/drug effects , Human T-lymphotropic virus 1/physiology , Interferon-alpha/pharmacology , Oxides/pharmacology , Antineoplastic Agents/pharmacology , Arsenic Trioxide , Cell Division/drug effects , Cell Line, Transformed , Cells, Cultured , Drug Synergism , Human T-lymphotropic virus 1/metabolism , Humans , Jurkat Cells , Leukocytes, Mononuclear/drug effects , Leukocytes, Mononuclear/virology , T-Lymphocytes/drug effects , T-Lymphocytes/virology , Tumor Cells, Cultured , Viral Proteins/biosynthesis
13.
Cell Adhes Commun ; 5(6): 437-49, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9791725

ABSTRACT

In intestinal inflammation, inflammatory cells infiltrate the submucosa and are found juxtaposed to intestinal epithelial cell (IEC) basolateral membranes and may directly regulate IEC function. In this study we determined whether macrophage (M phi), P388D1 and J774A.1, are coupled by gap junctions to IEC lines, Mode-K and IEC6. Using flow cytometric analysis, we show bi-directional transfer of the fluorescent dye, calcein (700 Da) between IEC and M phi resulting in a 3.5-20-fold increase in recipient cell fluorescence. Homocellular and heterocellular dye transfer between M phi and/or IEC was detected in cocultures of P388D1, J774A.1, Mode-K, IEC6 and CMT93. However, transfer between P388D1 and Mode-K was asymmetrical in that transfer from P388D1 to Mode-K was always more efficient than transfer from Mode-K to P388D1. Dye transfer was strictly dependent on IEC-M phi adhesion which in turn was dependent on the polarity of IEC adhesion molecule expression. Both calcein dye transfer and adhesion were inhibited by the addition of heptanol to cocultures. Furthermore we demonstrate both IEC homocellular, and M phi-IEC heterocellular propagation of calcium waves in response to mechanical stimulation, typical of gap junctional communication. Finally, areas of close membrane apposition were seen in electron micrographs of IEC-M phi cocultures, suggestive of gap junction formation. These data indicate that IEC and M phi are coupled by gap junctions suggesting that gap junctional communication may provide a means by which inflammatory cells might regulate IEC function.


Subject(s)
Cell Communication , Gap Junctions/metabolism , Intestinal Mucosa/metabolism , Macrophages/metabolism , Animals , Calcium Signaling , Cell Adhesion/drug effects , Cell Communication/drug effects , Cell Line , Cell Polarity , Cells, Cultured , Coculture Techniques , Female , Flow Cytometry , Fluoresceins/metabolism , Fluorescent Dyes/metabolism , Gap Junctions/ultrastructure , Heptanol/pharmacology , Intestinal Mucosa/cytology , Intestinal Mucosa/ultrastructure , Macrophages/ultrastructure , Macrophages, Peritoneal/metabolism , Macrophages, Peritoneal/ultrastructure , Mice , Mice, Inbred C3H , Microscopy, Electron , Tight Junctions/ultrastructure
14.
Am J Physiol ; 274(5): L673-7, 1998 05.
Article in English | MEDLINE | ID: mdl-9612281

ABSTRACT

We have previously demonstrated that recombinant human copper-zinc superoxide dismutase (rhCu,ZnSOD) is rapidly incorporated into cells of airways, respiratory bronchioles, and alveoli after intratracheal administration. The present study examines whether this cellular uptake is specific for rhCu,ZnSOD or whether other proteins are similarly incorporated into lung cells. Twenty-two newborn piglets (2-3 days old, 1.2-2.0 kg) were intubated and mechanically ventilated. Eight piglets received fluorescently labeled recombinant human manganese superoxide dismutase (rhMnSOD), six received fluorescently labeled albumin, two received free (unbound) fluorescent label intratracheally, and two piglets served as untreated controls. To determine whether endogenous surfactant was important in the process of intracellular uptake, four additional piglets were made surfactant deficient by repeated bronchoalveolar lavage and then given rhCu,ZnSOD intratracheally. All animals were killed after 30-60 min. Lung sections were examined blindly by laser confocal microscopy. Similar to our previous observations with rhCu,ZnSOD, intracellular uptake of rhMnSOD and albumin was noted throughout the lung. The free label did not localize intracellularly. The uptake of proteins did not appear to be affected by surfactant deficiency. rhMnSOD administration was associated with a greater than twofold increase in lung MnSOD activity. Data suggest that the cellular uptake of antioxidants and other proteins in the lung may reflect a nonspecific host defense system for clearing proteins from the lumen of airways and alveoli.


Subject(s)
Intracellular Membranes/metabolism , Lung/metabolism , Superoxide Dismutase/administration & dosage , Superoxide Dismutase/pharmacokinetics , Animals , Animals, Newborn , Humans , Intubation, Intratracheal , Lung/cytology , Pulmonary Surfactants/physiology , Recombinant Proteins , Serum Albumin/pharmacokinetics , Swine
15.
Cell Adhes Commun ; 5(2): 83-95, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9638330

ABSTRACT

Activated macrophages (M phi) found in the intestinal lesions of patients with inflammatory bowel disease (IBD) secrete many inflammatory mediators which can regulate intestinal epithelial cell (IEC) function. However, little is known about direct M phi-IEC interactions. Two potential mechanisms by which cells may interact are through specific receptor-ligand binding of adhesion molecules, such as integrins or cadherins, and by exchange of cytoplasmic substances through transmembraneous channels called gap junctions. We investigated whether M phi could adhere to epithelial cells in culture and form transmembrane communication channels as defined by dye transfer. Primary cultures of murine M phi and a M phi cell line, P388D1, adhered to Mode-K and IEC6, but not CMT-93 IEC. Antibody blocking studies determined that P388D1-Mode-K binding was partially dependent on beta 2 integrin (CD18) function, Mode-K constitutively expressed CD106 (VCAM-1) and cell associated fibronectin, while P388D1 expressed low levels of CD49d/CD29 (VLA4) but blocking antibodies to these surface molecules did not inhibit P388D1-Mode-K adherence. Transfer of calcein dye from M phi to IEC was quantitated by flow cytometry and was dependent on M phi-IEC adhesion. Dye transfer was concentration dependent in that the fluorescence intensity of Mode-K was proportional to the number of adherent P388D1 cells as well as the dye load of the M phi. These results indicate that M phi interact with IEC by adhesion and possibly through gap junctions and may thus regulate IEC function by direct cell-cell communication.


Subject(s)
Cell Adhesion Molecules/metabolism , Fluoresceins/metabolism , Fluorescent Dyes/metabolism , Intestinal Mucosa/metabolism , Macrophages/metabolism , Adenocarcinoma/pathology , Animals , Antibodies, Monoclonal/immunology , Antibodies, Monoclonal/pharmacology , Biological Transport , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , CD18 Antigens/physiology , Cell Adhesion , Cell Communication , Cells, Cultured , Connexin 43/metabolism , Epithelial Cells/metabolism , Female , Intestinal Mucosa/cytology , L Cells , Macrophages/cytology , Macrophages, Peritoneal/cytology , Macrophages, Peritoneal/metabolism , Mice , Mice, Inbred C3H , Rats , Rectal Neoplasms/pathology , Tumor Cells, Cultured
16.
Exp Cell Res ; 227(1): 23-32, 1996 Aug 25.
Article in English | MEDLINE | ID: mdl-8806447

ABSTRACT

The controlled invasiveness of the trophoblast is based on the balance between invasive properties at implantation and the differentiation program of the developing placenta. During placental development in rats a switch of connexin gene expression has been observed in parallel to the switch from the invasive to the differentiated phenotype of trophoblast cells. To investigate the role of connexin expression for trophoblast invasion, proliferation, and differentiation, we studied one rat trophoblast (HRP-1) and one rat choriocarcinoma cell line (Rcho-1). The choriocarcinoma cells were characterized by expression of cx31 and a lack of E-cadherin, corresponding to the invasive trophoblast in vivo, whereas HRP-1 cells expressed cx43, normally found in the spongiotrophoblast and in late giant cells, and E-cadherin. Upon retinoic acid treatment, Rcho-1 cells irreversibly lost cx31 expression, accompanied by a loss of functional coupling. No changes in regard to connexin expression and cell-cell communication could be observed in HRP-1 cells. In addition, treatment of Rcho-1 cells with retinoic acid for 7 days upregulated expression of cx43 transcript, but no protein could be found. Proliferation was clearly reduced and the mean volume of cells doubled from Day 4 to Day 7 of retinoic acid treatment in Rcho-1 cells, while both parameters were not affected in HRP-1 cells. Both cell lines showed a similar invasion rate using a Matrigel invasion assay, and invasion was equally suppressed upon retinoic acid treatment. Thus the different connexin expression appears more likely to play a role in regulating proliferation and differentiation along the multilineage pathway than invasiveness of rat trophoblast cells.


Subject(s)
Choriocarcinoma/physiopathology , Connexins/genetics , Gene Expression Regulation, Neoplastic/drug effects , Tretinoin/pharmacology , Animals , Cadherins/genetics , Calcium/analysis , Cell Communication/drug effects , Cell Division , Cell Movement , Choriocarcinoma/chemistry , Choriocarcinoma/pathology , Collagen , Connexin 43/genetics , Drug Combinations , Fluorescent Dyes , Gap Junctions/chemistry , Gene Expression Regulation, Developmental/drug effects , Isoquinolines , Laminin , Proteoglycans , RNA, Messenger/analysis , Rats , Trophoblasts/chemistry , Trophoblasts/cytology , Trophoblasts/physiology , Tumor Cells, Cultured
17.
Int J Cancer ; 65(2): 192-9, 1996 Jan 17.
Article in English | MEDLINE | ID: mdl-8567116

ABSTRACT

Lu-ECAM-1 is a lung-derived, venular endothelial cell adhesion molecule. It promotes the selective adhesion of lung-metastatic B16-F10 melanoma cells to endothelium under static conditions and mediates colonization of the lungs by the same tumor cells. To test whether Lu-ECAM-1 by itself is sufficient to cause vascular arrest of B16-F10 cells, we measured here under conditions of flow tumor cell adhesion to endothelia that express different amounts of Lu-ECAM-1 on their surfaces. At physiological shear stresses, adhesion of B16-F10 melanoma cells to endothelia correlates positively with the amount of Lu-ECAM-1 expression on the endothelial cell surface and inversely with the level of the applied shear stress. Tumor cell trajectories are biphasic; i.e., B16-F10 melanoma cells initially move along the endothelial surface with a velocity similar to the theoretical velocity, then arrest within a fraction of a second. Arrest is permanent for most B16-F10 melanoma cells at all shear stresses tested. Tumor cells never engaged in a rolling motion prior to arrest. Masking of the Lu-ECAM-1 ligand on the surface of B16-F10 melanoma cells with soluble Lu-ECAM-1 impedes arrest of tumor cells on the surface of the test endothelium. Purified Lu-ECAM-1 also mediates B16-F10 arrest, but arrest is mostly transient at shear stresses of 0.59 dynes/cm2 and higher, implying adhesion by single receptor/ligand bonds. Our data suggest that Lu-ECAM-1 plays a critical role in the recognition and initial arrest of murine melanoma cells in lung venules.


Subject(s)
Cell Adhesion Molecules/metabolism , Endothelium, Vascular/pathology , Melanoma/pathology , Animals , Cattle , Cell Adhesion , Endothelium, Vascular/metabolism , Flow Cytometry , Humans , Ligands , Melanoma/metabolism , Tumor Cells, Cultured
18.
Biophys J ; 66(6): 2202-9, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7521229

ABSTRACT

Prior to extravasation at sites of acute inflammation, neutrophils roll over activated endothelium. Neutrophil rolling is often characterized by the average rolling velocity. An additional dynamic feature of rolling that has been identified but not extensively studied is the fluctuation in the rolling velocity about the average. To analyze this characteristic further, we have measured the instantaneous velocity of bovine neutrophils interacting with lipopolysaccharide-stimulated bovine aortic endothelium at shear stresses of 1, 2, 3, and 4 dynes/cm2. The average velocities are quantitatively similar to those reported for human neutrophils rolling over reconstituted P-selectin at a surface density of 400 sites/microns 2. At all shear stresses tested, the population average variance in the instantaneous velocity is at least 2 orders of magnitude higher than the theoretical variance generated from experimental error, indicating that the neutrophils translate with a nonconstant velocity. Possible sources of the variance are discussed. These include "macroscopic" sources such as topological heterogeneity in the endothelium and microscopic sources, such as inherent stochastic formation and breakage of the receptor-ligand bonds that mediate the rolling. Regardless of the ultimate source of the variance, these results justify the use of mathematical models that incorporate stochastic processes to describe bond formation and breakage between the neutrophil and the endothelium and hence are able to generate variable velocity trajectories.


Subject(s)
Endothelium, Vascular/physiology , Neutrophils/physiology , Animals , Aorta, Thoracic , Cattle , Cell Adhesion Molecules/pharmacology , Cell Movement/drug effects , Cells, Cultured , Kinetics , Neutrophils/cytology , Neutrophils/drug effects , P-Selectin , Platelet Membrane Glycoproteins/pharmacology , Stress, Mechanical
19.
Invasion Metastasis ; 14(1-6): 164-76, 1994.
Article in English | MEDLINE | ID: mdl-7657509

ABSTRACT

Adhesion to vascular endothelium is a primary step in the colonization of select target organs by blood-borne cancer cells. Previous studies in our laboratory have shown that adhesion is followed by the establishment of fully functional gap junctional channels between the arrested tumor cell and the endothelium and that gap junctional communication might play an important role in extravasation. Here we report on a critical interdependence between endothelial cell adhesion and communication of lung-metastatic cancer cells. Gap junctions are assembled at focal adhesion contacts between tumor cells and endothelial cells where they mediate metabolic coupling between the junction-forming cell pair. The level of coupling depends on sufficient amounts of connexin43 (cx43) protein expression by both cell partners and, in a rate-limiting fashion, on the expression level of the receptor/ligand pair that mediates adhesion between tumor cells and the endothelium. This conclusion is based on our findings that (a) tumor cells with equal cx43 message, yet different adhesion potential for endothelial cells, differ significantly in their level of communication with the endothelium (e.g., R230AC-MET vs. R3230AC-LR), and (b) gap junctional communication between B16-F10 melanoma cells and lung-matrix-modulated endothelium can be effectively blocked by antiadhesive, anti-Lu-ECAM-1 monoclonal antibody 6D3 and by soluble Lu-ECAM-1. Significantly increased adhesion and communication levels in highly lung-metastatic carcinoma cells imply a role of gap junctional coupling in cancer metastasis, presumably by facilitating extravasation.


Subject(s)
Endothelium, Vascular/cytology , Gap Junctions/physiology , Lung Neoplasms/secondary , Melanoma, Experimental/secondary , Animals , Cattle , Cell Adhesion/physiology , Cell Adhesion Molecules/physiology , Cell Communication/physiology , Connexin 43/metabolism , Connexin 43/physiology , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Male , Melanoma, Experimental/metabolism , Melanoma, Experimental/pathology , Mice , Neoplastic Cells, Circulating/pathology , Rats
20.
J Cell Biol ; 115(5): 1375-82, 1991 Dec.
Article in English | MEDLINE | ID: mdl-1955478

ABSTRACT

Metastatic colonization of a secondary organ site is initiated by the attachment of blood-borne tumor cells to organ-specific adhesion molecules expressed on the surface of microvascular endothelial cells. Using digital video imaging microscopy and fluorescence activated cell sorting techniques, we show here that highly metastatic cells (B16-F10 murine melanoma and R3230AC-MET rat mammary adenocarcinoma cells) previously labeled with the fluorescent dye BCECF begin to transfer dye to endothelial cell monolayers shortly after adhesion is established. The extent of BCECF transfer to endothelial cell monolayers is dependent upon the number of BCECF-labeled tumor cells seeded onto the endothelial cell monolayer and the time of coculture of the two cell types, as visualized by an increase in the number of BCECF-positive cells among cells stained with an endothelial cell-specific mAb. Dye transfer to BAEC monolayers proceeds with a progressive loss of fluorescence intensity in the BCECF-labeled tumor cell population with time of coculture. The transfer of dye is bidirectional and sensitive to inhibition by 1-heptanol. In contrast, poorly metastatic B16-F0 melanoma cells and non-metastatic R3230AC-LR mammary adenocarcinoma cells do not efficiently couple with vascular endothelial cells. It is inferred from these experiments and from the amounts of connexin43 mRNA expressed by tumor cells that tumor cell/endothelial cell communication is mediated by gap junctional channels and that this interaction may play a critical role in tumor cell extravasation at secondary sites.


Subject(s)
Cytoplasm/metabolism , Endothelium, Vascular/metabolism , Melanoma/secondary , Animals , Cattle , Cells, Cultured , Endothelium, Vascular/cytology , Fluorescence , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...